Retrospective Study
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 14, 2014; 20(26): 8612-8616
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8612
Follow-up of patients with pseudotumoral chronic pancreatitis: Outcome and surveillance
Félix Ignacio Téllez-Ávila, Álvaro Villalobos-Garita, Marc Giovannini, Carlos Chan, Jorge Hernández-Calleros, Luis Uscanga, Miguel Ángel Ramírez-Luna
Félix Ignacio Téllez-Ávila, Miguel Ángel Ramírez-Luna, Endoscopy Department, Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”, Mexico City, CP 14000, México
Álvaro Villalobos-Garita, Gastroenterology Department, Hospital Calderón Guardia, CCSS, San José, CP 10105, Costa Rica
Marc Giovannini, Endoscopic Unit, Paoli-Calmettes Institute, 232 Bd St-Marguerite, 13273 Marseille cedex 9, France
Carlos Chan, Surgery Department, Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”, Mexico City, CP 14000, México
Jorge Hernández-Calleros, Luis Uscanga, Gastroenterology Department, Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”, Mexico City, CP 14000, México
Author contributions: Téllez-Ávila FI design the report; Téllez-Ávila FI, Villalobos-Garita A, Chan C, Hernández-Calleros J, Uscanga L, and Ramírez-Luna MÁ were attending doctors for patients; Téllez-Ávila FI and Ramírez-Luna MÁ performed endoscopies; Téllez-Ávila FI, Villalobos-Garita A, Hernández-Calleros J, Chan C, and Giovannini M organized the report; and Téllez-Ávila FI, Villalobos-Garita A, and Giovannini M wrote the paper.
Correspondence to: Félix Ignacio Téllez-Ávila, MD, MSc, PhD, Endoscopy Department, Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”, Vasco de Quiroga 15. Col. Sección XVI. Del. Tlalpan, Mexico City, CP 14000, Mexico. felixtelleza@gmail.com
Telephone: +525-54-870900 Fax: +525-54-870900
Received: November 26, 2013
Revised: February 14, 2014
Accepted: April 5, 2014
Published online: July 14, 2014
Core Tip

Core tip: Actually, there are no clear recommendations for follow-up of patients with chronic pancreatitis and solid pancreatic mass lesions. We followed-up patients with chronic pancreatitis and solid pancreatic mass lesions and we assessed the final outcome and identified an optimal surveillance interval. We found that almost one-third of patients with chronic pancreatitis had pseudotumoral chronic pancreatitis, and 22.2% had unresectable pancreatic adenocarcinoma less than 2 mo after the initial diagnosis. Endoscopic ultrasound fine needle aspiration can miss malignancy in nearly 25% of patients with pseudotumoral chronic pancreatitis.